Duloxetine HCL DR 40 MG cap 30S
Ended Awarded
- Contract number
- SPE2DB25FQ74P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,980
Award facts
- Contract value 100% obligated
- $1,979.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units) valued at $1,979.60. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction. The order is scheduled for ultimate completion by September 16, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio under the DLA prime contract encompasses a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains, enabling support for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Duloxetine HCL is a commonly utilized medication in military and federal healthcare settings for treating depression and anxiety-related conditions. AmerisourceBergen's consistent receipt of non-set-aside, competitively awarded contracts demonstrates its capability to meet rigorous federal procurement standards and supply requirements at scale.
Quick answers
Who was awarded contract SPE2DB25FQ74P?
SPE2DB25FQ74P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FQ74P worth?
The government has obligated $1,980 on SPE2DB25FQ74P.
Is contract SPE2DB25FQ74P an order under another contract?
Yes. SPE2DB25FQ74P is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ74P competed?
The extent of competition for SPE2DB25FQ74P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award